Crohn's Disease and Colitis Trial, Recruiting NCT06231264 Sponsor: Xijing Hospital Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT06231264
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been diagnosed with ulcerative colitis for at least 3 months
  • People whose ulcerative colitis is rated as moderately active, based on a specific scoring system called the Mayo score (a score of 4–10) and a related internal examination score of 2–3 (confirm with trial site)
  • People whose ulcerative colitis has not responded to at least one type of medication

Who may not be able to join:

  • People who have never received any treatment for their ulcerative colitis
  • People who are currently experiencing a severe sudden flare-up of ulcerative colitis
  • People who have previously had bowel surgery related to their colitis, or whose condition is considered so severe that surgery may be needed very soon
  • People who have a bowel infection causing their symptoms (confirm with trial site)
  • People who have other serious conditions affecting the whole body (confirm with trial site)
  • People who are currently pregnant or breastfeeding
  • People who have a known allergy to electrode patches (adhesive patches used to deliver electrical signals through the skin)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kaichun Wu, Xijing Hospital

Phone: +8615529202305

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xijing Hospital
Registry
ClinicalTrials.gov
Start date
19 January 2024
Est. completion
1 March 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Clinical response

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov